Global healthcare investment firm OrbiMed Advisors invested $4.3 million in Otic Pharma, an Israeli company that develops foam-based treatments for ear diseases. “Foam-Otic”, according to the company, is considered to be a more efficient drug than ear drops, with lower and less frequent doses. Otic Pharma is about to complete a clinical trial to test the […]

Can-Fite BioPharma obtained US Food and Drug Administration (FDA) Orphan Drug Status for CF102 – a drug for primary liver cancer (hepatocellular carcinoma.) The drug was found to be safe in preclinical and Phase I clinical trials. Orphan Drug Status is granted for drugs being developed for the treatment of diseases that affect a small […]

Prolor Biotech Inc. reported positive results in a study of its new version of the hemophilia drug Factor VIIa-CTP in a pre-clinical trial on mice. The study showed that mice which received the longer-acting version of the drug showed a higher survival and recovery rate over a longer period of time, compared to those that […]

Tiltan Pharma Ltd. announced it has started phase II of its clinical trial for its new drug for pancreatic cancer, following approval by the Israeli Ministry of Health. The drug is designed to prevent blood flow to tumors and prevent their growth. The second phase of the trial will include 80 patients: 40 with newly […]

A genetically engineered form of artemisinin, a natural compound that produces large quantities of the anti-malaria drug - was announced Sunday by the Yissum Research Development Company – the Hebrew University of Jerusalem’s technology transfer company.